My group has a strong background in understanding the mechanisms of tissue damage during transplant rejection, with particular emphasis on chemokine-mediated tissue inflammation. This work is focused largely on the regulatory interactions between leukocytes and endothelial and epithelial cells. Within this area, specific interests include the role of chemokines in inflammation, their interaction with cell surface glycosaminoglycans and signal transduction mechanisms mediated by them.